Lars Fruergaard Jørgensen, Chief Executive Officer of Novo Nordisk, additionally rejects that the downgrade has actually had any type of influence on the firm’s monitoring reshuffle previously this year.
发布者:BY CHRISTOPHER DUE KARLSSON,转转请注明出处:https://robotalks.cn/novo-nordisk-boss-explains-downgrade-with-copy-sales-we-have-been-surprised-by-the-scale/